Main Article Content
Gurumoorthi Ragesh
Department of Obstetrics and Gynaecology, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Sheila K. Pillai
Department of Obstetrics and Gynaecology, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Ravi Keerthana
Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Durai Kalai Selvi
Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Jothikumar Krishna Priya
Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Kumar Karthik
Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, Tamil Nadu, India.
Abstract
Background and purpose of the study: Polycystic ovary syndrome (PCOS) is a hormonal disorder common amongwomen of reproductive age. There is a greater risk of metabolic syndrome in women with PCOS imply on elevated risk for the development of cardiovascular diseases. This study aimed to assess the metabolic risk between PCOD and non PCOD patients.
Methodology: It’s a cross sectional study conducted among 57 PCOD and 68 Non PCOD patients in the Obstetrics and Gynaecology. Females above the age of 23 years were included. The data were collected from patients with their consent through an interview method based questionnaire is used to assess the metabolic risk factors among patients with andwithout PCOD. The collected data were analyzed with IBM.SPSS statistics software 23.0 version.
Results & Discussion: This study was conducted in 57 PCOD and 57 non PCOD patients, among 57 Non PCOS patients 17.5 % of patients were found to be at metabolic risk and 82.5% of patients were not at risk. Among 57 PCOS patients, 87.7 % of patients were found to be at metabolic risk and 12.3 % of patients were not at risk.
Conclusion: The result of this study concludes that women with PCOS have nearly 6 fold higher metabolic risk when compared with non-PCOS patients. These findings support the idea that PCOS should be consider a general healthdisorder with serious health implication and indicate that physician should comprehensively screen all women with PCOSfor the metabolic risk.
Keywords: Metabolic syndrome, PCOS & non-PCOS patients, elevated body mass index, waist hip ratio, lipid profile,blood glucose and irregular menstrual cycle.